Pernicious anaemia and the risk of rheumatoid arthritis: A bidirectional
two-sample Mendelian randomization study
Abstract
Background: Pernicious anaemia (PA) and rheumatoid arthritis (RA) often
co-occur and are commonly reported in clinical observational studies,
but whether there is a causal relationship between the two diseases
remains uncertain. Objective: The purpose of our study was to
investigate the relationship between Pernicious anaemia and rheumatoid
arthritis using Mendelian randomization (MR). Materials and
methods: Single-nucleotide polymorphisms (SNPs) associated with diseases
of PA and RA were selected as instrumental variables (IVs) at a
genome-wide significance level (P < 5.0 × 10−8). Summary-level
data of PA and RA were collected from large-scale genome-wide
association studies, with a sample size of 397,378 and 490,025,
respectively. MR analyses were performed using the random-effects
inverse variance weighted (IVW) method, and sensitivity analyses were
further operated to test the robustness. Results: Our study discovered a
potentially causal effect between PA and RA. The presence of PA may
increase the risk of RA by 78% by the IVW method [odds ratios (OR) =
1.78; 95% confidence interval (CI): 1.17–2.70; P = 0.007]. However,
we found that RA was not causally associated with PA (IVW: OR = 1.25,
95% CI: 0.94–1.64, P = 0.120). Sensitivity analyses using other
methods showed similar associations, and no evidence of pleiotropy was
found by MR-Egger regression (P = 0.825, P = 0.774, respectively) in the
bidirectional MR study. Conclusion: We found a potentially causal
relationship between PA and RA in European population. Novel and
satisfactory medicine for PA may be suitable to RA, and this potential
warrants further investigation.